Stemcell Technologies and Brigham and Women’s Hospital Signs Exclusive License Agreement for Kidney Organoid Technology

Shots:

• The agreement will focus on commercialization of kidney organoid technology, for generation of human pluripotent stem cell-derived kidney organoids
• This technology enables the growth of organoids/ mini-organs, having key features of renal development and physiology in vitro and is developed by one of the professor at Brigham and Women’s Hospital
• The kidney organoids provide reproductive and adaptable framework for forming renal physiology, injury and disease at developmental stages

Click here to read full press release/ article | Ref:  Stemcell Technologies | Image: Kevin Hardiman